2019年10月
Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer.
Molecular and clinical oncology
- ,
- ,
- ,
- ,
- 巻
- 11
- 号
- 4
- 開始ページ
- 376
- 終了ページ
- 382
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.3892/mco.2019.1912
- 出版者・発行元
- SPANDIDOS PUBL LTD
Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.
- リンク情報
-
- DOI
- https://doi.org/10.3892/mco.2019.1912
- PubMed
- https://www.ncbi.nlm.nih.gov/pubmed/31497297
- PubMed Central
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719253
- Web of Science
- https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000496290500008&DestApp=WOS_CPL
- ID情報
-
- DOI : 10.3892/mco.2019.1912
- ISSN : 2049-9450
- eISSN : 2049-9469
- PubMed ID : 31497297
- PubMed Central 記事ID : PMC6719253
- Web of Science ID : WOS:000496290500008